Friday, 16 October 2026European Markets

BOUYGUES And VINCI Have A High Dividend Yield And Return On Equity In The Engineering & Construction Industry.

Loading stream...

(vianews) - bouygues (en.pa) is among this list of stock assets with the highest dividend rate and return on equity on the engineering & construction industry.

financial asset price forward dividend yield return on equity
bouygues (en.pa) €37.83 5.87% 8.6%
vinci (dg.pa) €118.76 4.16% 15.71%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. bouygues (en.pa)

5.87% forward dividend yield and 8.6% return on equity

bouygues sa, together with its subsidiaries, operates in the construction, energy, telecom, media, and transport infrastructure sectors in france and internationally. the company designs, builds, renovates, operates, and deconstructs building, infrastructure, and industrial projects; develops urban planning, residential, and commercial projects; builds and maintains roads and motorways, airport runways, ports, industrial logistics hubs, external works and amenities, reserved-lane public transport, recreational facilities, and environmental projects, as well as undertakes civil engineering, road safety, and signaling activities; produces, distributes, sells, and recycles aggregates, emulsions, asphalt mixes, ready-mix concrete, and bitumen; construction, renewal, and maintenance of rail networks; and installation and maintenance of pipes and pipelines. it also provides design, installation, and maintenance services in various fields that include cooling and fire protection, digital and ict, electrical, and mechanical and robotics, as well as heating, ventilation, and air conditioning. in addition, the company produces tf1, tmc, tfx, tf1, and lci complementary tv channels; operates ushuaïa tv, histoire tv, tv breizh, and serieclub channels; produces, broadcasts, and distributes content; operates la seine musical entertainment and concert venue; and entertainment and leisure comprising licenses, podcasts, music production, and live events. further, it offers telecom services; and mobile and fixed network services. the company was founded in 1952 and is based in paris, france.

earnings per share

as for profitability, bouygues has a trailing twelve months eps of €2.92.

pe ratio

bouygues has a trailing twelve months price to earnings ratio of 12.96. meaning, the purchaser of the share is investing €12.96 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.6%.

growth estimates quarters

the company's growth estimates for the present quarter and the next is a negative 20.8% and a negative 8.8%, respectively.

yearly top and bottom value

bouygues's stock is valued at €37.83 at 07:40 est, under its 52-week high of €38.26 and way above its 52-week low of €29.82.

volume

today's last reported volume for bouygues is 965487 which is 17% above its average volume of 825186.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, bouygues's stock is considered to be oversold (<=20).

more news about bouygues.

2. vinci (dg.pa)

4.16% forward dividend yield and 15.71% return on equity

vinci sa, together with its subsidiaries, engages in concessions, energy, and construction businesses in france and internationally. the concessions segment manages motorway concessions; operates airports; and highways, railways, and stadium. its energy segment provides services to the manufacturing sector, infrastructure, facilities management, and information and communication technology; and industrial and energy-related services, which includes development of renewable energy assets, as well as engineering, procurement, and construction projects in the energy sector. the construction segment engages in designing and carrying out projects, which includes general contractor; geotechnical and structural engineering and related digital activities, as well as provision of services in nuclear engineering; proximity networks with active local companies, such as building, civil engineering, roadworks, rail works, and water works; property development, including residential and commercial properties; and management of serviced residences and property services. vinci sa was founded in 1899 and is headquartered in nanterre, france.

earnings per share

as for profitability, vinci has a trailing twelve months eps of €8.18.

pe ratio

vinci has a trailing twelve months price to earnings ratio of 14.52. meaning, the purchaser of the share is investing €14.52 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.71%.

moving average

vinci's value is way above its 50-day moving average of €106.46 and higher than its 200-day moving average of €111.77.

yearly top and bottom value

vinci's stock is valued at €118.76 at 07:40 est, under its 52-week high of €120.62 and way above its 52-week low of €97.44.

revenue growth

year-on-year quarterly revenue growth grew by 4.6%, now sitting on 71.4b for the twelve trailing months.

more news about vinci.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com